Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

BACKGROUND: Bacterial vaginosis (BV) affects 30–50% of women at some time in their lives and is an embarrassing and distressing condition which can be associated with potentially serious comorbidities. Current antibiotic treatments such as metronidazole are effective but can result in side effects,...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong-Buisseret, Lindsay, Brittain, Clare, David, Miruna, Dean, Gillian, Griffiths, Frances, Hepburn, Trish, Jackson, Louise, Kai, Joe, Montgomery, Alan, Roberts, Tracy, Thandi, Sukhwinder, Ross, Jonathan D. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880606/
https://www.ncbi.nlm.nih.gov/pubmed/31775859
http://dx.doi.org/10.1186/s13063-019-3731-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880606/
https://www.ncbi.nlm.nih.gov/pubmed/31775859
http://dx.doi.org/10.1186/s13063-019-3731-7

Ejemplares similares